Flu in a post-COVID world: Learnings from SHIVERS-V

+Practice

In print

Vaccines

Flu in a post-COVID world: Learnings from SHIVERS-V

By Sam Marsh

Wednesday 9 October 2024, 12:35 AM

Figure 1. Monthly rates of presentations to general practice for any respiratory illness, expressed as a percentage of all consultation interactions [Reproduced with permission: Anthony Dowell (University of Otago), Jayden MacRae (DataCraft Analytics)]

This article presents some major themes from research into the impact of the COVID-19 pandemic on other viral respiratory illnesses

Key points, COVID-19 border closures and non-pharmaceutical interventions stopped influenza and RSV transmission and altered the pattern of resp General practic, Pract Green w Pale Yellow

Vaccines

Infectious Disease

Respiratory Health

Research

References

1. Huang QS, Turner N, Wood T, et al. Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand. Influenza Other Respir Viruses 2024;18(2):e13247.

2. Turner N, Aminisani N, Huang S, et al. Comparison of the burden and temporal pattern of hospitalisations associated with respiratory syncytial virus (RSV) before and after COVID-19 in New Zealand. Influenza Other Respir Viruses 2024;18(7):e13346.

3. ESR. Respiratory Illness Dashboard.

4. Dowell A, Huang S, McIntosh C, et al. Towards new forms of communication and surveillance: a mixed methods study of rapid respiratory virus assessment in general practice during the SARS-CoV-2 pandemic. J Prim Health Care 2024;16 July online.

How to Treat

Behavioural activation tools

A range of approaches is needed to manage mental health presentations. In this article, specialist GP Sophie Jadwiga Ball describes two tools that can be employed within a GP consultation and provides the evidence-based theory behind their use. She also presents numerous examples to demonstrate how you can apply these tools in practice

Wednesday 9 October 2024, 12:45 AM